Ulimorelin clinical trials
Also written TZP-101.
How each study uses ulimorelin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
9 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 0
Norgine (4) · Tranzyme, Inc. (3) · Lyric Pharmaceuticals (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ulimorelin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel ResectionCompletedPhase 3NorgineNCT01710982Written as TZP-101
- A Study to Assess Ulimorelin in Healthy SubjectsCompletedPhase 1Lyric PharmaceuticalsNCT02993055Written as Ulimorelin
- Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE TrialCompletedPhase 2Lyric PharmaceuticalsNCT02784392Written as Ulimorelin
- Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic GastroparesisCompletedPhase 2Tranzyme, Inc.NCT00612014Written as TZP-101
- Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal SurgeryCompletedPhase 2Tranzyme, Inc.NCT00617552Written as TZP-101
- Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy VolunteersCompletedPhase 1NorgineNCT01405612Written as Ulimorelin
- Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy SubjectsCompletedPhase 1NorgineNCT01405599Written as Ulimorelin
- A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101CompletedPhase 1NorgineNCT01668199Written as TZP-101
- Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic GastroparesisCompletedPhase 1Tranzyme, Inc.NCT00639808Written as TZP-101
Codes
What other systems call ulimorelin · ClinicalTrials.gg INT005274
- MeSH (NLM) C528884ulimorelinOne source NLM
- UNII (FDA) LGI67MCW2SULIMORELINConfirmed FDA, NLM, Wikidata
- Wikidata Q21098959ulimorelinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152792UlimorelinOne source FDA
- DrugBank DB12128One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C528884 | ulimorelin | One source NLM |
| UNII (FDA) | LGI67MCW2S | ULIMORELIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q21098959 | ulimorelin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152792 | Ulimorelin | One source FDA |
| DrugBank | DB12128 | — | One source Wikidata |
Also registered as ulimorelin hydrochloride (UNII 662MCS79XH).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.